Suppr超能文献

橙花叔醇、环磷酰胺及其联合用药对乳腺癌细胞系MCF-7的抗癌疗效。

Anticancer efficacy of nerolidol, cyclophosphamide, and their combination against breast cancer cell line MCF-7.

作者信息

Tousif Md, Nadeem Masood, Tabassum Ms, Rizvi M Moshahid Alam, Haque Syed Ehtaishamul

机构信息

Department of Pharmacology, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110025, India.

Genome Biology Lab, Department of Biosciences, Jamia Millia Islamia, New Delhi, 110025, India.

出版信息

Med Oncol. 2025 Aug 19;42(10):430. doi: 10.1007/s12032-025-02997-7.

Abstract

In cancer, chemotherapeutic agents like cyclophosphamide (CP), is the most frequently used drug but the side effects caused by it, limits it's application. Therefore, creation of anticancer medicines with high efficacy and no or minimum side effects is a priority. In recent times, research on natural bioactive has been increased since they are efficient, safe, and economical. We earlier proved that Nerolidol (NER), a naturally derived sesquiterpene alcohol is a natural bioactive compound that could significantly reduce the CP-induced organ toxicities in Swiss albino mice. Thus, in this study, we intended to evaluate the anti-cancer property of NER alone and its potentiating effect in combination with CP in Michigan Cancer Foundation-7 (MCF-7) breast cancer cell line. MCF-7 is one of the most extensively used human breast cancer cell line, primarily because it closely resembles estrogen receptor-positive (ER), luminal-type breast cancer, which accounts for a significant proportion (~ 70%) of clinical breast cancer cases. MCF-7 cells are also non-invasive and less aggressive, which makes them suitable for early-stage tumor modelling and cytotoxicity screening. It provides a well-characterized and clinically relevant model for evaluating the efficacy of anticancer agents. MTT assay, clonogenic assay, cytotoxicity, wound healing assay, and cell cycle arrest was assessed to determine the anticancer properties of NER, CP, and their combination against MCF-7 cells. The change in nuclear morphology was determined by 4', 6-diamidino-2- phenylindole (DAPI) to assess apoptosis. The NER, CP, and their combination at IC concentration was found to be cytotoxic against MCF-7 cells, inhibited colony formation, migration of MCF-7 cells and arrested the cell cycle at G0/G1, G2/M, and S phase, respectively. Thus, NER, CP, and their combination showed anticancer property against MCF-7 cells, when administered alone or in combination, but the combination treatment proved to be the best.

摘要

在癌症治疗中,像环磷酰胺(CP)这样的化疗药物是最常用的药物,但其所引起的副作用限制了它的应用。因此,研发高效且无副作用或副作用极小的抗癌药物成为当务之急。近年来,对天然生物活性物质的研究不断增加,因为它们高效、安全且经济。我们之前证明了橙花叔醇(NER),一种天然衍生的倍半萜醇,是一种天然生物活性化合物,能够显著降低CP对瑞士白化小鼠造成的器官毒性。因此,在本研究中,我们旨在评估单独使用NER的抗癌特性及其与CP联合使用对密歇根癌症基金会-7(MCF-7)乳腺癌细胞系的增效作用。MCF-7是使用最广泛的人乳腺癌细胞系之一,主要是因为它与雌激素受体阳性(ER)、管腔型乳腺癌非常相似,而这种类型的乳腺癌在临床乳腺癌病例中占很大比例(约70%)。MCF-7细胞也是非侵袭性且侵袭性较小的,这使得它们适合用于早期肿瘤建模和细胞毒性筛选。它为评估抗癌药物的疗效提供了一个特征明确且与临床相关的模型。通过MTT法、克隆形成试验、细胞毒性试验、伤口愈合试验和细胞周期阻滞来评估NER、CP及其组合对MCF-7细胞的抗癌特性。通过4',6-二脒基-2-苯基吲哚(DAPI)检测细胞核形态变化以评估细胞凋亡。发现NER、CP及其在IC浓度下的组合对MCF-7细胞具有细胞毒性,并分别抑制MCF-7细胞的集落形成、迁移以及使细胞周期阻滞在G0/G1期、G2/M期和S期。因此,NER、CP及其组合单独或联合给药时均对MCF-7细胞显示出抗癌特性,但联合治疗被证明是最佳的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验